test44
https://www.cytel.com/blog/how-to-determine-if-your-clinical-trial-has-sufficient-data
June 22, 2022
It can be difficult to estimate just how much time and data you need to address the multitude of considerations that..
Read article
test44
https://www.cytel.com/blog/leveraging-advanced-statistical-software-to-optimize-clinical-development
May 24, 2022
Traditionally, clinical trials are expensive, long in duration, and have low success rate. But with the advent of rich..
Read article
test44
https://www.cytel.com/blog/bayesian-statistics-and-its-applications-new-webinar-by-professor-yuan-ji
April 21, 2022
Sophisticated Bayesian Methods are gaining a lot of traction as they bring flexibility and speed to clinical trial..
Read article
test44
https://www.cytel.com/blog/career-perspectives-interview-with-charles-warne-associate-director-of-biostatistics
April 12, 2022
In this edition of the Career Perspectives series, I interview Charles Warne, Associate Director of Biostatistics at..
Read article
test44
https://www.cytel.com/blog/a-spotlight-on-our-scientific-community
April 1, 2022
At the end of every year, scientists from across Cytel’s business units are nominated for Cytel’s Spotlight Awards,..
Read article
test44
https://www.cytel.com/blog/winter-weekend-read-increased-adoption-of-innovative-designs
March 11, 2022
Every year, sponsors hesitating to use a complex innovative clinical trial design routinely miss opportunities to..
Read article
test44
https://www.cytel.com/blog/what-is-ahead-for-clinical-trial-design
January 19, 2022
The past two years have been transformative for Cytel. Most notably, the global COVID-19 pandemic unleashed an..
Read article
test44
https://www.cytel.com/blog/the-rapidly-evolving-need-for-master-protocols
October 6, 2021
Master Protocols are advanced and innovative clinical trial designs that can evaluate multiple therapies and disease..
Read article
test44
https://www.cytel.com/blog/kyle-wathen-talks-to-outsourcing-pharma-on-the-need-for-statistical-innovation
October 1, 2021
The COVID-19 pandemic elevated the challenge of designing and executing clinical trials within a substantially..
Read article
